Mac-2 binding protein and galectin-3 expression in mucinous tumours of the ovary: an annealing control primer system and immunohistochemical study

References

• Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43–66
   PubMed Web of Science ®Google Scholar
• Harrison M L, Jameson C, Gore M E. Mucinous ovarian cancer. Int J Gynecol Cancer 2008; 18: 209–214
   PubMed Web of Science ®Google Scholar
• Fujita M, Enomoto T, Murata Y. Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes. Mol Cell Endocrinol 2003; 202: 97–99
   PubMed Web of Science ®Google Scholar
• Pieretti M, Hopenhayn-Rich C, Khattar N H, Cao Y, Huang B, Tucker T C. Heterogeneity of ovarian cancer: relationships among histological group, stage of disease, tumor markers, patient characteristics, and survival. Cancer Invest 2002; 20: 11–23
   PubMed Web of Science ®Google Scholar
• Hwang I T, Kim Y J, Kim S H, Kwak C I, Gu Y Y, Chun J Y. Annealing control primer system for improving specificity of PCR amplification. Biotechniques 2003; 35: 1180–1184
   PubMed Web of Science ®Google Scholar
• Iacobelli S, Arno E, D'Orazio A, Coletti G. Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res 1986; 46: 3005–3010
   PubMed Web of Science ®Google Scholar
• Koths K, Taylor E, Halenbeck R, Casipit C, Wang A. Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J Biol Chem 1993; 268: 14245–14249
   PubMed Web of Science ®Google Scholar
• Ullrich A, Sures I, D'Egidio M, et al. The secreted tumor-associated antigen 90K is a potent immune stimulator. J Biol Chem 1994; 269: 18401–18407
   PubMed Web of Science ®Google Scholar
• Inohara M, Akahani S, Koths K, Raz A. Interactions between galectin-3 and Mac-2 binding protein mediate cell-cell adhesion. Cancer Res 1996; 56: 4530–4534
   PubMed Web of Science ®Google Scholar
• Inohara H, Akahani S, Raz A. Galectin-3 stimulates cell proliferation. Exp Cell Res 1998; 245: 294–302
   PubMed Web of Science ®Google Scholar
• Matarrese P, Fusco O, Tinari N, et al. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer 2000; 85: 545–554
   PubMed Web of Science ®Google Scholar
• Nangia-Makker P, Honjo Y, Sarvis R, et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 2000; 156: 899–909
   PubMed Web of Science ®Google Scholar
• Barondes S H, Cooper D N, Gitt M A, Leffler H. Galectins. Structure and function of a large family of animal lectins. J Biol Chem 1994; 269: 20807–20810
   PubMed Web of Science ®Google Scholar
• Grassadonia A, Tinari N, Iurisci I, et al. 90K (Mac-2 BP) and galectins in tumor progression and metastasis. Glycoconj J 2004; 19: 551–556
   Web of Science ®Google Scholar
• Linsley P S, Horn D, Marquardt H, et al. Identification of a novel serum protein secreted by lung carcinoma cells. Biochemistry 1986; 25: 2978–2986
   PubMed Web of Science ®Google Scholar
• Rea A, Calmieri G, Tinari N, et al. 90K is a serum marker of poor prognosis in non-Hodgkin's lymphoma patients. Oncol Rep 1994; 1: 723–725
   PubMed Web of Science ®Google Scholar
• Scambia G, Panici P B, Baiocchi G, Perrone L, Iacobelli S, Mancuso S. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer. Anticancer Res 1988; 8: 761–764
   PubMed Web of Science ®Google Scholar
• Zeimet A G, Natoli C, Herold M, et al. Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer. Int J Cancer 1996; 68: 34–38
   PubMed Web of Science ®Google Scholar
• Koopmann J, Thuluvath P J, Zahurak M L, et al. Mac-2 binding protein is a diagnostic marker for biliary tract carcinoma. Cancer 2004; 101: 1609–1615
   PubMed Web of Science ®Google Scholar
• Kunzli B M, Berberat P O, Zhu Z W, et al. Influences of the lysosomal associated membrane proteins (Lamps-1, Lamps-2) and Mac-2 binding protein (Mac-2 BP) on the prognosis of pancreatic carcinoma. Cancer 2002; 94: 228–239
   PubMed Web of Science ®Google Scholar
• Marchetti A, Tinari N, Buttitta F, et al. Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Cancer Res 2002; 62: 2535–2539
   PubMed Web of Science ®Google Scholar
• Park Y P, Choi S C, Kim J H, et al. Up-regulation of Mac-2 binding protein by hTERT in gastric cancer. Int J Cancer 2006; 120: 813–820
   Web of Science ®Google Scholar
• Ulmer T A, Keeler V, Loh L, et al. Tumor-associated antigen 90K/Mac-2-binding protein: Possible role in colon cancer. J Cell Biochem 2006; 98: 1351–1366
   PubMed Web of Science ®Google Scholar
• van den Brule F A, Berchuck A, Bast R C, et al. Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Eur J Cancer 1994; 30: 1096–1099
   Web of Science ®Google Scholar
• Iurisci I, Tinari N, Natoli C, Angelucci D, Cianchetti E, Iacobelli S. Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res 2000; 6: 1389–1393
   PubMed Web of Science ®Google Scholar